<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fabino Enterprises Ltd (formerly Fabino Life Sciences Ltd) has submitted an initial disclosure to BSE confirming that, as of 31st March 2025, it does not qualify as a 'Large Corporate' under SEBI's framework (Chapter XII of the operational circular dated August 10, 2021, as updated, and the revised framework circular dated October 19, 2023). The company has stated it does not meet the applicability criteria laid out in Clause 3.2 of the relevant SEBI circular. Consequently, it is not required to make any further disclosures under this framework for the financial year 2025-26. The letter is signed by Kanchi Gehlot, Company Secretary and Compliance Officer, and dated April 29, 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that the company falls below the thresholds required for additional SEBI disclosures applicable to large corporates.